Parth Shah
on
Parth Shah
Register Valuer | CA | CPA | 15+ Years of Experiance
Parth Shah is the Founder and Team Leader of the company, bringing extensive expertise in business valuation and financial advisory.
Getting the valuation of financial instruments right is not a compliance formality. It is the single most critical factor for successful fundraising, merger negotiations, tax compliance, and investor reporting. For founders, CFOs, and finance leaders dealing with convertible notes, CCPS, ESOPs, derivatives, and unlisted securities, an accurate valuation determines the actual price at which capital changes hands and the tax liability that follows.
India’s regulatory environment has grown significantly more demanding. SEBI’s Merchant Banker (Amendment) Regulations, effective January 3, 2026, explicitly removed valuation from the scope of merchant bankers and directed that all valuations must now be conducted by independent IBBI (Insolvency and Bankruptcy Board of India) Registered Valuers. SEBI’s updated AIF valuation framework and the CBDT’s Rule 11UA amendments have further raised the bar for technical precision. At My Valuation, led by CA Parth Shah (FCA, CPA USA, IBBI Registered Valuer), we regularly navigate these requirements for startups, AIFs, and corporates across India.
This guide explains the primary financial instrument valuation methods, the Ind AS accounting framework, the valuation of complex instruments, and the regulatory compliance rules that govern every transaction in 2026.
Key Takeaways
- Financial instruments’ valuation is the process of determining the fair value of monetary contracts, including equity shares, debentures, derivatives, CCPS, and convertible notes, for purposes of financial reporting, fundraising, and regulatory compliance.
- Under Ind AS 113, fair value is defined as the exit price in an orderly transaction between market participants at the measurement date, not the historical cost.
- Three primary valuation approaches apply to financial instruments: the Market Approach, the Income Approach (DCF), and the Asset Approach, with the method selection determined by the instrument type and regulatory purpose.
- SEBI’s Merchant Banker (Amendment) Regulations, effective January 3, 2026, require all valuations to be conducted by IBBI Registered Valuers, removing this function from merchant banker scope.
- Complex instruments such as CCPS, CCDs, warrants, and ESOPs require specialized models including the Option Pricing Model (OPM), Probability Weighted Expected Return Method (PWERM), and the Black-Scholes-Merton (BSM) model.
- India’s regulatory framework prescribes different valuation methods for the same instrument depending on the statute: Companies Act 2013, FEMA, Income Tax Act (Rule 11UA), and SEBI regulations each have distinct requirements.
- The SEBI AIF valuation framework, refined through the September 2024 circular and the February 2026 depository reporting mandate, now requires standardized valuation policies, independent valuers, and NAV reporting to NSDL and CDSL.
- An IBBI Registered Valuer’s report is the only legally defensible document for statutory valuations under the Companies Act 2013, IBC proceedings, and SEBI-regulated transactions.
What Are Financial Instruments and How Are They Classified?
A financial instrument is a contract that gives rise to a financial asset in one entity and a financial liability or equity instrument in another. Under Ind AS 32 (Financial Instruments: Presentation), financial instruments span a wide range of contractual arrangements, from simple bank deposits and trade receivables to complex convertible securities and structured derivatives.
For valuation purposes, financial instruments are grouped into three broad categories:
Equity Instruments: Ordinary shares, preference shares (including CCPS), warrants, and options representing ownership or future ownership in an entity.
Debt Instruments: Bonds, debentures, non-convertible debentures (NCDs), and compulsorily convertible debentures (CCDs), representing a contractual obligation to pay cash.
Hybrid and Derivative Instruments: Instruments that contain features of both debt and equity or derive their value from an underlying asset. Examples include convertible notes, SAFEs (Simple Agreements for Future Equity), interest rate swaps, and foreign exchange forwards.
The valuation method appropriate for each category differs substantially, which is why a one-size-fits-all approach invariably produces numbers that fail regulatory or investor scrutiny.
Why Is Accurate Financial Instruments Valuation a Necessity, Not an Option?
The following table outlines the primary use cases for financial instruments valuation and the corresponding service area at My Valuation:
| Use Case | Core Requirement | Relevant Service |
| Fundraising and M&A | Establishing fair market value for equity and debt instruments for deal pricing | Startup Valuation and Business Valuation Services |
| ESOP and Sweat Equity | Determining exercise price and tax perquisite value at grant and exercise dates | ESOP Valuation Services |
| Tax Compliance | Rule 11UA FMV computation, Section 50CA capital gains | Valuation Under Income Tax Act |
| Foreign Investment | FEMA floor price for share issuance or transfer to non-residents | Valuation Under FEMA/FDI |
| Financial Reporting | Ind AS 109 and Ind AS 113 fair value measurement for balance sheet | Complex Financial Instruments Valuation |
| AIF Portfolio | SEBI-mandated periodic fair value of portfolio companies | AIF Valuation Services |
| Insolvency | IBBI Registered Valuer determination of fair value and liquidation value | Valuation Under IBC |
An incorrect valuation does not simply produce a bad number. It can trigger tax demands, regulatory rejections, investor disputes, and in the case of FEMA violations, penalties from the Reserve Bank of India.
What Are the Three Primary Financial Instrument Valuation Methods?
Three globally accepted valuation approaches apply to financial instruments. The choice among them depends on the instrument type, the availability of market data, and the regulatory framework governing the transaction.
The Market Approach: Benchmarking Against Real Transactions
The Market Approach determines an asset’s value by reference to prices of identical or comparable instruments transacted in an active market. It is the most reliable method when sufficient comparable data exists and is the preferred approach under Ind AS 113 for instruments where observable market inputs are available.
Within the Market Approach, two primary methods apply:
Guideline Public Company Method (GPCM): Compares the subject company or instrument to publicly traded peers using valuation multiples such as EV/Revenue, EV/EBITDA, or Price/Earnings. A discount for lack of marketability (DLOM) is typically applied when valuing unlisted instruments to reflect the illiquidity premium.
Comparable Transaction Method (CTM): References prices paid in recent arm’s-length acquisitions of similar companies or instruments. This method is particularly relevant for M&A and for PWERM scenario modelling under the Rule 11UA framework.
The Market Approach is best suited for later-stage companies with identifiable public comparables and for instruments with active secondary markets.
The Income Approach: Discounting Future Economic Benefit
The Income Approach values an instrument based on the present value of the future cash flows it is expected to generate. This is the preferred method under FEMA regulations for equity instrument valuation and is one of the two accepted methods under Rule 11UA of the Income Tax Rules, 1962.
Discounted Cash Flow (DCF) Model: The DCF model projects free cash flows over a defined forecast period and discounts them to present value using a risk-adjusted discount rate. For Indian startups, this is typically the Weighted Average Cost of Capital (WACC), which incorporates an India Equity Risk Premium (currently estimated at 9.15% per Damodaran’s January 2026 dataset for India) and a size or company-specific risk premium.
Capitalization of Earnings Method: Used for stable, mature businesses with predictable earnings, this method divides normalized earnings by a capitalization rate to arrive at value. It is rarely used for early-stage startups but is appropriate for established SMEs seeking business valuation for succession or exit purposes.
The Asset Approach: Sum of Parts at Fair Value
The Asset Approach calculates entity value by aggregating the fair market values of all identifiable assets and subtracting liabilities. It is most applicable in liquidation scenarios, holding company structures, or where the Income and Market Approaches cannot produce reliable results.
Adjusted Net Asset Value (ANAV): This method adjusts book values of assets and liabilities to current fair market values. It is the prescribed approach for NAV-based valuation under Rule 11UA and is commonly used in IBC resolution proceedings where liquidation value must be established.
How Does Ind AS 109 and Ind AS 113 Define Fair Value for Financial Instruments?
Ind AS 109 (Financial Instruments) and Ind AS 113 (Fair Value Measurement) form the accounting backbone for financial instrument valuation in India. Together, these standards define both what is being measured and how it must be measured for financial reporting purposes.
Under Ind AS 109, all financial assets and liabilities are initially recognized at fair value (generally evidenced by transaction price) and subsequently measured at either amortized cost, Fair Value Through Other Comprehensive Income (FVTOCI), or Fair Value Through Profit or Loss (FVTPL), depending on the entity’s business model and the instrument’s cash flow characteristics.
Ind AS 113 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. This is an exit price concept, not the price paid to acquire the asset.
Ind AS 113 establishes a three-level fair value hierarchy that governs which inputs a valuer must prioritize:
| Level | Input Type | Example |
| Level 1 | Quoted prices in active markets (most reliable) | Listed equity share prices on NSE/BSE, open-ended mutual fund NAVs |
| Level 2 | Observable market inputs other than Level 1 | Interest rate benchmarks, comparable private transaction multiples, yield curves |
| Level 3 | Unobservable inputs requiring significant judgement (least reliable) | DCF projections for unlisted startups, Black-Scholes inputs for private company options |
Most complex financial instruments held by unlisted Indian companies fall into Level 3, which requires the highest degree of documentation, assumption transparency, and professional judgement. This is precisely why an independent, credentialed valuer is not optional but essential.
Need A Fair Value Report For Your CCPS, CCD, Or ESOP Pool Under Ind AS 109?
My Valuation’s IBBI-registered valuers deliver compliant, audit-ready fair value reports for CCPS, CCD, ESOPs, and other financial instruments in line with Ind AS 109 requirements. Get a free consultation today.
Get A Free Valuation ConsultationHow Are Complex Financial Instruments Valued in India?
Complex financial instruments, by definition, contain rights and obligations that cannot be captured by a simple income or asset approach. Their value is path-dependent, meaning it changes based on which exit scenario ultimately materializes. This is the domain where specialized models become unavoidable.
Valuing CCPS (Compulsorily Convertible Preference Shares)
CCPS are the standard instrument used by venture capital and private equity investors in Indian startups. Their valuation is not just about the face value of the preference share. It requires accounting for the liquidation preference (whether 1x or 2x, participating or non-participating), anti-dilution rights (broad-based weighted average or full ratchet), and conversion ratios.
The Option Pricing Model (OPM) treats each security class as a series of call options on the total enterprise value, with the liquidation preference acting as the strike price. This method allocates enterprise value across the capital structure in a way that correctly reflects each class’s economic rights. OPM is particularly relevant for companies with multiple rounds of preferred equity where the waterfall of payouts is complex.
The Probability Weighted Expected Return Method (PWERM) models multiple future scenarios (IPO, strategic sale, secondary transaction, liquidation) and assigns a probability to each. The payout to each security class in each scenario is then probability-weighted and discounted to present value. PWERM is typically preferred when the company has a near-term liquidity event on the horizon and can credibly specify the range of outcomes.
Valuing CCDs (Compulsorily Convertible Debentures) and Zero-Coupon CCDs
CCDs are hybrid instruments containing both a debt component (interest accrual or implied yield) and an equity component (the conversion option). As per Ind AS 109, the debt and equity components of a compound financial instrument must be bifurcated and valued separately at initial recognition.
Zero-coupon CCDs, increasingly common in Indian bridge rounds in 2026, carry no interest payments during the tenure. Instead, the investor’s return is delivered entirely through the conversion discount or the implied equity upside at maturity. The valuation of a zero-coupon CCD requires calculating the present value of the notional principal at maturity using a market-rate discount rate, and separately valuing the embedded equity conversion option using an option pricing model.
Valuing ESOPs and Warrants
Under Ind AS 102 (Share-Based Payments), the fair value of employee stock options must be measured at the grant date using an option pricing model. The Black-Scholes-Merton (BSM) model is the most widely used approach in India. Key inputs include the current share price, exercise price, expected option life, expected volatility (often implied from comparable listed companies), risk-free rate (typically the yield on Indian government securities of matching tenure), and expected dividends.
For private companies where historical price volatility data does not exist, expected volatility is typically estimated using the historical volatility of a peer group of publicly listed companies in the same industry, adjusted for stage of development and capital structure differences.
A Worked Example: Financial Instruments Valuation for TechNova Solutions Pvt. Ltd.
Consider TechNova Solutions Pvt. Ltd., a Bengaluru-based B2B SaaS startup with ARR of Rs. 8 crore and growing at 60% annually. The company has raised a Series A of Rs. 25 crore at a pre-money valuation of Rs. 100 crore through CCPS with a 1x non-participating liquidation preference.
ESOP Valuation Under Ind AS 102: TechNova grants 1,00,000 options to employees at an exercise price of Rs. 50 per share. Using the Black-Scholes-Merton model with an implied equity share FMV of Rs. 320 (derived via OPM from the Series A round using the backsolve method), an expected volatility of 45% (based on listed SaaS peers), an expected option life of 4 years, and a risk-free rate of 6.95%, the fair value per option is approximately Rs. 198. TechNova must recognize Rs. 1.98 crore as ESOP compensation expense in its P&L over the vesting period.
Rule 11UA FMV for Angel Tax Purposes: Although the Angel Tax under Section 56(2)(viib) has been abolished for shares issued from April 1, 2025 onwards, TechNova must still determine FMV under Rule 11UA for FEMA compliance when issuing CCPS to its Singapore-based VC fund. The DCF method, using a 5-year projection with a terminal growth rate of 5% and a WACC of 22%, produces an FMV of Rs. 104 crore. This becomes the floor price below which the CCPS cannot be issued to the non-resident investor.
This single company requires at least three distinct valuations, for ESOP accounting, FEMA compliance, and the Companies Act Section 62 preferential allotment certificate, each with a different method, regulatory basis, and signing authority.
What Is the Regulatory Framework for Financial Instruments Valuation in India?
India’s valuation regulatory landscape is multi-layered. The same financial instrument can require different methodologies and different signatories depending on which statute governs the transaction.
| Regulation | Purpose | Key Method / Requirement |
| Companies Act 2013, Section 62(1)(c) | Preferential allotment of shares | IBBI Registered Valuer mandatory; blended DCF and Market approach |
| Rule 11UA, Income Tax Rules 1962 | FMV for FEMA compliance and tax; now includes 5 new methods for non-residents (CBDT Notification No. 81/2023) | NAV or DCF for residents; OPM, PWERM, CCM, RCM, CTM available for non-residents |
| FEMA Non-Debt Instruments Rules 2019 | Floor price for FDI transactions | Internationally accepted pricing methodology; DCF is globally preferred |
| SEBI ICDR Regulations 2018 | Preferential allotment by listed companies | SEBI-registered Merchant Banker or Registered Valuer as per updated MB Regulations effective January 3, 2026 |
| IBC 2016 | Fair value and liquidation value for insolvency resolution | IBBI Registered Valuer mandatory for both fair value and liquidation value |
| Ind AS 109 and Ind AS 113 | Financial reporting fair value | Level 1 to Level 3 hierarchy; method based on instrument type |
A critical regulatory development in 2026: the SEBI (Merchant Bankers) (Amendment) Regulations, effective January 3, 2026, have explicitly excluded valuation from the permitted activities of Merchant Bankers. All valuations for regulatory and reporting purposes must now be performed by IBBI Registered Valuers. This marks a decisive shift toward independent, specialized valuation professionals for all statutory purposes.
Working With Complex Capital Structures, AIF Portfolios, Or Cross-Border Transactions?
My Valuation’s IBBI-registered valuers provide compliant financial instrument valuations for complex capital structures, AIF portfolios, cross-border transactions, and regulatory reporting across India. Speak with our valuation experts today.
Speak To A Valuation ExpertWhat Are the Latest SEBI AIF Valuation Requirements in 2024-2026?
Alternative Investment Funds are subject to a rapidly evolving valuation framework under SEBI’s supervision. Fund managers and compliance teams should note the following current requirements:
SEBI AIF Master Circular (May 2024), Chapter 22: Mandates a standardized two-track valuation framework. Track 1 applies market-based (mark-to-market) pricing for listed securities. Track 2 requires DCF, Comparable Company Analysis, or OPM for unlisted securities, early-stage startups, and complex financial instruments.
SEBI Circular dated September 19, 2024: Reformed the independent valuer eligibility criteria, extending the reporting timeline to 7 months and broadening the pool of qualified independent valuers. AIFs must now appoint independent IBBI Registered Valuers (or entities meeting the eligibility norms) for assets that cannot be marked to market.
SEBI AIF (Third Amendment) Regulations, November 18, 2025: Introduced a lighter regulatory touch for Accredited Investor-only (AI-only) funds and Large Value Funds (LVFs), extending certain operational flexibilities while maintaining independent valuation requirements.
SEBI Circular dated February 6, 2026: Directed all AIFs to report unit NAV to depositories (NSDL and CDSL) through their Registrars and Transfer Agents (RTAs). With AIF units now mandatorily held in dematerialized form for all new investments from July 1, 2025, NAV data must be routed through the depository infrastructure to give investors a standardized, centralized view of their unit values.
For fund managers, these changes mean that valuation is no longer an internal administrative exercise. It is a depository-reportable, investor-visible number that must be defensible at every quarterly or monthly cycle.
Best Practices for Financial Instruments Valuation: Achieving Accuracy and Defensibility
A high-quality valuation is not just a number. It is a defensible analytical conclusion supported by documented assumptions and clearly cited methodology.
Prioritize Observable Inputs and Transparency
Ind AS 113’s fair value hierarchy is not optional guidance. It is a mandatory sequencing rule. Valuers must use Level 1 inputs wherever available, move to Level 2 when Level 1 data is not accessible, and use Level 3 only when the instrument’s specific characteristics prevent the use of any observable data.
When Level 3 inputs are unavoidable, such as DCF projections for a pre-revenue startup, every assumption must be explicitly stated: the revenue growth rate, gross margin trajectory, terminal growth rate, WACC components, and the basis for the equity risk premium used. Investors and auditors will challenge every input; the report must anticipate this scrutiny.
Match the Method to the Instrument and the Regulatory Purpose
A DCF valuation done for FEMA compliance is not interchangeable with a Net Asset Value computation done for Rule 11UA purposes. A single company may need separate reports for the same equity instrument depending on whether it is being issued to a resident or non-resident investor, and whether the purpose is tax filing, Companies Act compliance, or financial reporting.
Do not rely solely on DCF for early-stage startups. Use complementary approaches such as the Scorecard Method, the Berkus Method, or the VC Method for pre-revenue businesses, and triangulate the results to arrive at a defensible range of values.
Run Sensitivity Analysis on Key Inputs
Terminal value typically accounts for 60% to 80% of the total DCF value. A small change in the terminal growth rate or WACC can shift the valuation by 20% to 30%. A professionally prepared report must include sensitivity tables showing how the value changes as each key input varies. This is not optional for any report that will face investor or regulatory review.
Ensure the Right Credential for the Right Purpose
For Companies Act 2013 compliance, IBBI proceedings, and SEBI-regulated transactions, the signatory must be an IBBI Registered Valuer. For ESOP accounting under Ind AS 102 for Indian-incorporated companies, an IBBI Registered Valuer or a qualified CA can typically sign. For 409A valuations covering US-incorporated entities or US-based employees, the report must meet IRS standards and is typically signed by a CPA-qualified professional.
My Valuation holds all three credentials: CA Parth Shah is an FCA, a CPA (USA), and an IBBI Registered Valuer, which means a single firm can sign reports across all these regulatory purposes without the compliance risks that come from mismatched credentials.
Conclusion
Financial instruments valuation in India is no longer a simple exercise of plugging numbers into a model. It is a regulatory, methodological, and professional discipline that requires the right credential, the right method, and the right documentation for each specific purpose. Whether you are valuing CCPS for a Series B round, computing ESOP fair value under Ind AS 102, or preparing a Rule 11UA certificate for a foreign investor, the stakes of getting it wrong are significant.
My Valuation is one of India’s leading IBBI-registered valuation firms, specializing in the full spectrum of complex financial instruments valuation, startup and business valuation, ESOP valuation, AIF portfolio valuation, and regulatory compliance for FEMA, SEBI, and the Companies Act 2013. Led by CA Parth Shah (FCA, CPA USA, IBBI Registered Valuer), our team delivers audit-ready, regulatory-defensible reports across all asset classes.
Get A Credentialed, Defensible Valuation Report
My Valuation’s IBBI-registered valuers deliver accurate, audit-ready valuation reports that stand up to investor, auditor, regulatory, and tax authority scrutiny. Book your free consultation today.
Book Your Free ConsultationFrequently Asked Questions (FAQs)
1. What is the difference between Fair Value and Fair Market Value (FMV) for financial instruments in India?
Fair Value, defined under Ind AS 113, is an accounting concept representing the exit price in an orderly transaction between market participants at the measurement date. Fair Market Value under the Income Tax Act and FEMA is a legal and regulatory concept that is computed using prescribed rules such as Rule 11UA, which may produce a different number than the commercial fair value even for the same instrument.
2. Which valuation method does FEMA require for issuing shares to a non-resident investor?
FEMA (Foreign Exchange Management Non-Debt Instruments Rules, 2019) requires that shares issued to non-residents be priced at or above FMV determined using any internationally accepted pricing methodology on an arm’s-length basis. The DCF method is globally accepted and most commonly used. CBDT Notification No. 81/2023 also introduced five new Rule 11UA methods for non-residents, including PWERM, OPM, CCM, RCM, and CTM.
3. Is an IBBI Registered Valuer mandatory for all financial instrument valuations in India?
An IBBI Registered Valuer is mandatory for valuations under the Companies Act 2013 (Section 62 preferential allotment, Section 247 statutory valuations), IBC 2016 proceedings, and as per the SEBI Merchant Banker Amendment Regulations effective January 3, 2026, for SEBI-regulated transaction valuations. For ESOP accounting under Ind AS 102 or FEMA valuations, a qualified CA may also sign in certain contexts, but an IBBI Registered Valuer provides the strongest regulatory defense.
4. Why is DCF alone insufficient for early-stage startup valuation?
The DCF model relies on stable, forecastable future cash flows. For pre-revenue or early-stage startups, projecting cash flows over 5 years requires highly speculative assumptions, producing results that vary dramatically with minor input changes. Early-stage startup valuations in India therefore use complementary methods such as the Scorecard Method, Berkus Method, or VC Method, which are grounded in qualitative milestones and comparable funding data rather than long-range financial projections alone.
5. What is the Black-Scholes-Merton model and when is it used for financial instrument valuation?
The Black-Scholes-Merton (BSM) model is a mathematical model for pricing European-style options. In India, it is the primary tool for ESOP valuation under Ind AS 102, where it calculates the fair value of stock options at the grant date using inputs including current share price, exercise price, expected option life, volatility, risk-free rate, and expected dividends. It is also used for valuing warrants and the embedded equity component of convertible instruments.
6. What are the latest SEBI requirements for AIF portfolio valuation in 2026?
As of 2026, SEBI requires AIFs to follow a standardized two-track valuation framework under Chapter 22 of the AIF Master Circular (May 2024). Listed securities are valued mark-to-market; unlisted securities and complex instruments must use DCF, Comparable Company Analysis, or OPM by an independent IBBI Registered Valuer. The February 2026 SEBI Circular further mandates that all AIFs report unit NAV to NSDL and CDSL through their RTAs, making the valuation a depository-reportable, investor-accessible number.
7. How much does a financial instruments valuation report cost in India?
The cost of a financial instruments valuation report in India depends on the instrument type, the complexity of the capital structure, the regulatory purpose, and the level of documentation required. An ESOP valuation certificate for a simple capital structure typically starts at Rs. 25,000 to Rs. 50,000. A full DCF-based CCPS or CCD valuation for a multi-round company with complex preferences can range significantly higher. My Valuation provides a free initial consultation to scope the requirement and provide a transparent estimate.
